SCHEMBL20157445

SCHEMBL20157445

COCCOc1ncc2c(n1)[nH]c(=O)n2C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 12/20 0.45
▸ PDE3A Q14432 12/20 0.45
▸ PDE2A O00408 9/20 0.45
▸ P2RY12 Q9H244 4/20 0.42
▸ MTOR P42345 1/20 0.40
▸ NUDT1 P36639 2/20 0.39
▸ TLR7 Q9NYK1 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13194946 0.78 PDE3B (0.48) PDE3BPDE3APDE2AP2RY12MTOR
SCHEMBL20157656 0.72 TYRO3 (0.49) PDE3BPDE3APDE2AP2RY12
SCHEMBL29349996 0.71 PDE3B (0.47) PDE3BPDE3APDE2AP2RY12ADORA2A
SCHEMBL12830376 0.71 PDE3B (0.47) PDE3BPDE3APDE2AP2RY12ADORA2A
SCHEMBL10006861 0.71 PDE3B (0.47) PDE3BPDE3APDE2AP2RY12ADORA2A
SCHEMBL30011988 0.69 ADORA2B (0.45) PDE3AADORA2AADORA2BGRIN1GRIN2B
SCHEMBL10006551 0.69 DUT (0.44) PDE3BPDE3APDE2AP2RY12GAA
SCHEMBL30358089 0.69 PDE3B (0.49) PDE3BPDE3APDE2AP2RY12ADORA2A
SCHEMBL31465468 0.69 XDH (0.41) PDE3BPDE3APDE2AP2RY12TLR7
SCHEMBL20157464 0.68 TSHR (0.36) NUDT1TLR7CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086593-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE 礼沃(上海)医药科技有限公司 2018-05-17 — — WO disclosed
Send feedback